ConductScience.org, home

Paper320261

Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellular analysis of immunosuppression.

Haran-Ghera N and 2 others. J Immunol, 1977. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellular analysis of immunosuppression. Papers, record 320261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/320261

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellular analysis of immunosuppression.
PubMed
Journal
J Immunol
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
1.37
iCite
Revised in PubMed
2021-12-03
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Haran-Ghera NN
2Ben-Yaakov MM
3Peled AA

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic VariationMajor topic
Immunity, CellularMajor topic
Immunosuppression TherapyMajor topic
Leukemia, Radiation-InducedMajor topic
RetroviridaeMajor topic
Animals
Bone Marrow
Bone Marrow Cells
Bone Marrow Transplantation
Female
Hemolytic Plaque Technique
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Thymus Gland
Transplantation, Isogeneic

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
22457934I-region linked complementing loci in resistance to viral leukemogenesis in the mouse.Immunogenetics1980https://conductscience.org/library/papers/22457934PubMed
8635197Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.Cancer Immunol Immunother1995https://conductscience.org/library/papers/8635197PubMed
7439957Genetic resistance to murine leukemia induced by different radiation leukemia virus variants; a comparative study on the role of the H-2 complex.Immunogenetics1980https://conductscience.org/library/papers/7439957PubMed
6969087Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice.Br J Cancer1980https://conductscience.org/library/papers/6969087PubMed
6293111Role of the major histocompatibility complex in resistance to viral leukemia; its effect on the preleukemic stage of leukemogenesis.Springer Semin Immunopathol1982https://conductscience.org/library/papers/6293111PubMed
6260638H-21-linked control of immunological resistance to viral leukemogenesis as a response to preleukemic cells.Immunogenetics1981https://conductscience.org/library/papers/6260638PubMed
6256461
In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.
J Exp Med1980https://conductscience.org/library/papers/6256461PubMed
6246529Expression of peanut agglutinin receptors on virus-induced preleukemic cells in mice.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6246529PubMed
6227381Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesis.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6227381PubMed
2860713Prothymocytes as target cells of T cell leukemogenesis in the mouse.Surv Immunol Res1985https://conductscience.org/library/papers/2860713PubMed
2424597Promotion of tumor antigenicity in EL-4 leukemia cells by hydrostatic pressure.Cancer Immunol Immunother1986https://conductscience.org/library/papers/2424597PubMed
2186773Insulin-tumour interrelationship in EL4 lymphoma or thymoma-bearing mice. I. Alloxan-diabetic or non-diabetic mice.Br J Cancer1990https://conductscience.org/library/papers/2186773PubMed
2124137Insulin-tumour interrelationships in EL4-lymphoma or thymoma-bearing mice. II. Effects of dietary omega-3 and omega-6 polyunsaturated fatty acids.Br J Cancer1990https://conductscience.org/library/papers/2124137PubMed
2021954Potentiation of delayed-type hypersensitivity response to syngeneic tumors in mice prevaccinated with cells modified by hydrostatic pressure and crosslinking.Cancer Immunol Immunother1991https://conductscience.org/library/papers/2021954PubMed
1764366Insulin-tumour interrelationships in thymoma bearing mice. Effects of dietary glucose and fructose.Br J Cancer1991https://conductscience.org/library/papers/1764366PubMed
1731346Treatment of premalignancy: prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1731346PubMed
1341721Role of pineal melatonin and melatonin-induced-immuno-opioids in murine leukemogenesis.Med Oncol Tumor Pharmacother1992https://conductscience.org/library/papers/1341721PubMed
197197Resistance genes to murine leukemia in the I immune response gene region of the H-2 complex.J Exp Med1977https://conductscience.org/library/papers/197197PubMed
116228Effective tumor immunization induced by cells of elevated membrane-lipid microviscosity.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/116228PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/320261

GET https://conductscience.org/api/papers/v1/320261/authors